Related Experiment Videos
Oxidative enzymopathies and vascular disease
Jane A Leopold1, Joseph Loscalzo
1Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass 02118, USA.
Arteriosclerosis, Thrombosis, and Vascular Biology
|March 26, 2005
Summary
Genetic variations in antioxidant and pro-oxidant enzymes can disrupt vascular redox balance, leading to increased oxidative stress and heightened risk of cardiovascular diseases like atherothrombosis.
Area of Science:
- Vascular Biology
- Oxidative Stress
- Genetics
Background:
- Reactive oxygen species (ROS) are crucial for vascular signaling but excess ROS can cause dysfunction.
- A delicate balance between ROS production and antioxidant defenses maintains vascular health.
- Perturbations in this redox balance lead to increased oxidant stress in blood vessels.
Purpose of the Study:
- To explore the role of genetic polymorphisms in pro-oxidant and antioxidant enzymes in vascular disease.
- To understand how these genetic variations influence ROS production and antioxidant capacity.
- To define the collective impact of these genetic factors on vascular health.
Main Methods:
- Review of literature on genetic polymorphisms of key vascular enzymes.
- Analysis of how these polymorphisms affect ROS generation and antioxidant defense.
- Association studies linking genetic variations to atherothrombotic cardiovascular disease risk.
Main Results:
- Heritable polymorphisms in pro-oxidant enzymes (e.g., NAD(P)H oxidase) modulate ROS production and cardiovascular risk.
- Deficiencies in antioxidant enzymes (e.g., catalase, glutathione peroxidases) promote ROS accumulation and vascular disease risk.
- These genetic variations individually cause uncompensated oxidant stress, collectively termed oxidative enzymopathies.
Conclusions:
- Genetic polymorphisms in vascular enzymes significantly impact redox balance.
- Oxidative enzymopathies represent a collective genetic predisposition to vascular dysfunction and disease.
- Understanding these genetic factors is crucial for assessing individual risk for atherothrombotic cardiovascular disease.